| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,659 |
11,518 |
$1.24M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,355 |
6,551 |
$785K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,807 |
3,386 |
$578K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
12,338 |
10,039 |
$435K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
8,350 |
2,321 |
$325K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,746 |
2,323 |
$214K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,378 |
2,119 |
$177K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,905 |
1,611 |
$176K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
906 |
849 |
$133K |
| 71046 |
Radiologic examination, chest; 2 views |
6,695 |
5,910 |
$124K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,541 |
1,422 |
$103K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
1,481 |
1,356 |
$100K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,880 |
2,333 |
$75K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,654 |
2,568 |
$75K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,266 |
1,641 |
$55K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
750 |
663 |
$53K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,412 |
2,182 |
$48K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,633 |
1,394 |
$46K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,134 |
1,069 |
$44K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,104 |
7,358 |
$42K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,275 |
1,137 |
$39K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
23,802 |
18,877 |
$38K |
| 20610 |
|
831 |
725 |
$36K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
599 |
536 |
$36K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,006 |
1,758 |
$35K |
| 99233 |
Prolong inpt eval add15 m |
601 |
423 |
$33K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
197 |
172 |
$33K |
| 80061 |
Lipid panel |
7,909 |
7,340 |
$33K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,084 |
4,345 |
$32K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
19,911 |
16,138 |
$31K |
| 71045 |
Radiologic examination, chest; single view |
2,444 |
2,032 |
$30K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,140 |
2,061 |
$29K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,161 |
1,077 |
$28K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
136 |
119 |
$28K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,363 |
1,179 |
$25K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,221 |
2,067 |
$25K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
253 |
221 |
$24K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
349 |
314 |
$24K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,131 |
235 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
35,017 |
26,484 |
$22K |
| 80053 |
Comprehensive metabolic panel |
7,263 |
6,100 |
$20K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
530 |
489 |
$19K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,876 |
4,601 |
$19K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
479 |
116 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,575 |
6,076 |
$16K |
| 80076 |
|
10,936 |
9,456 |
$16K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
277 |
265 |
$16K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
611 |
209 |
$13K |
| 94060 |
|
238 |
226 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
289 |
256 |
$12K |
| 83721 |
|
4,074 |
3,586 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,120 |
1,681 |
$11K |
| 82607 |
|
2,318 |
2,155 |
$10K |
| 73030 |
|
901 |
761 |
$10K |
| 82728 |
|
2,258 |
2,000 |
$9K |
| 71250 |
|
309 |
281 |
$8K |
| 83550 |
|
2,831 |
2,593 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
716 |
626 |
$7K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
114 |
103 |
$7K |
| 84439 |
|
2,110 |
1,910 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
171 |
162 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
78 |
68 |
$6K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
178 |
155 |
$5K |
| 86140 |
|
5,826 |
4,910 |
$5K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
384 |
148 |
$5K |
| 99000 |
|
1,569 |
1,371 |
$5K |
| 72100 |
|
206 |
185 |
$5K |
| 82746 |
|
981 |
906 |
$5K |
| 87088 |
|
2,840 |
2,488 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
96 |
63 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
865 |
703 |
$4K |
| 83540 |
|
2,120 |
1,982 |
$4K |
| 80306 |
|
1,703 |
1,489 |
$4K |
| 83735 |
|
4,363 |
3,455 |
$4K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
49 |
30 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
179 |
177 |
$3K |
| 84460 |
|
2,238 |
2,023 |
$3K |
| 84450 |
|
2,251 |
2,035 |
$3K |
| 83880 |
|
1,182 |
952 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,213 |
1,096 |
$3K |
| 87631 |
|
118 |
114 |
$3K |
| 85651 |
|
2,316 |
2,004 |
$3K |
| 85610 |
|
3,414 |
1,872 |
$3K |
| 73562 |
|
258 |
213 |
$3K |
| 87186 |
|
1,431 |
1,267 |
$2K |
| 93017 |
|
53 |
48 |
$2K |
| 81001 |
|
5,619 |
4,869 |
$2K |
| 82043 |
|
2,044 |
1,896 |
$2K |
| 87070 |
|
416 |
381 |
$2K |
| 87077 |
|
1,680 |
1,502 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
529 |
493 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
495 |
453 |
$2K |
| 73630 |
|
228 |
193 |
$2K |
| 81025 |
|
1,367 |
1,235 |
$2K |
| 93226 |
|
75 |
64 |
$2K |
| 73502 |
|
197 |
175 |
$2K |
| 73610 |
|
174 |
150 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
119 |
118 |
$2K |
| 82570 |
|
1,256 |
1,088 |
$2K |
| 83690 |
|
2,778 |
2,377 |
$1K |
| 84153 |
|
261 |
228 |
$1K |
| 85027 |
|
598 |
515 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
493 |
453 |
$1K |
| 86900 |
|
31 |
26 |
$1K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
72 |
31 |
$1K |
| 99024 |
|
96 |
86 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
71 |
70 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
27 |
24 |
$1K |
| 81002 |
|
815 |
758 |
$908.56 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
16 |
15 |
$698.30 |
| 87205 |
|
354 |
326 |
$690.68 |
| 76642 |
|
29 |
26 |
$592.35 |
| Q3014 |
Telehealth originating site facility fee |
54 |
53 |
$544.79 |
| 93971 |
|
14 |
14 |
$519.82 |
| 81003 |
|
1,464 |
1,351 |
$399.46 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
56 |
52 |
$394.97 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
26 |
24 |
$316.08 |
| 83615 |
|
240 |
201 |
$294.89 |
| 73564 |
|
13 |
12 |
$291.69 |
| 85379 |
|
369 |
316 |
$285.73 |
| 94726 |
|
81 |
79 |
$271.16 |
| 83655 |
|
21 |
21 |
$259.77 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
220 |
201 |
$244.81 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
661 |
566 |
$241.34 |
| 72070 |
|
15 |
13 |
$201.78 |
| 94729 |
|
100 |
98 |
$199.48 |
| 84100 |
|
147 |
131 |
$165.18 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$161.16 |
| 82565 |
|
165 |
155 |
$157.61 |
| 82550 |
|
523 |
497 |
$152.73 |
| 86803 |
|
29 |
26 |
$132.35 |
| 99441 |
|
12 |
12 |
$130.79 |
| 87075 |
|
15 |
12 |
$119.71 |
| 82274 |
|
41 |
39 |
$102.25 |
| 87081 |
|
54 |
51 |
$100.81 |
| 93227 |
|
14 |
12 |
$95.30 |
| 93225 |
|
28 |
24 |
$93.48 |
| 84484 |
|
2,339 |
1,891 |
$81.22 |
| T1015 |
Clinic visit/encounter, all-inclusive |
24 |
18 |
$78.65 |
| J2704 |
Injection, propofol, 10 mg |
2,378 |
1,995 |
$69.73 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
157 |
119 |
$64.39 |
| 87040 |
|
390 |
263 |
$61.92 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
175 |
164 |
$60.92 |
| 87390 |
|
14 |
14 |
$52.00 |
| 73130 |
|
14 |
12 |
$46.23 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,060 |
1,728 |
$44.76 |
| 86702 |
|
14 |
14 |
$43.16 |
| 86701 |
|
14 |
14 |
$35.92 |
| 83605 |
|
673 |
585 |
$35.26 |
| A4206 |
Syringe with needle, sterile, 1 cc or less, each |
412 |
381 |
$28.83 |
| 82150 |
|
16 |
13 |
$25.48 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,142 |
886 |
$24.32 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,327 |
1,934 |
$22.72 |
| 87340 |
|
13 |
13 |
$20.89 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,886 |
1,616 |
$18.60 |
| 82948 |
|
409 |
284 |
$17.68 |
| 85018 |
|
14 |
13 |
$14.52 |
| 84550 |
|
39 |
37 |
$13.33 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$11.89 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
679 |
413 |
$8.93 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,739 |
1,351 |
$8.11 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
135 |
126 |
$6.79 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
21 |
12 |
$6.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
504 |
416 |
$4.41 |
| 81015 |
|
17 |
16 |
$3.47 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
14 |
$2.21 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,203 |
1,780 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
343 |
278 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
16 |
15 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,771 |
1,474 |
$0.00 |
| 88312 |
|
43 |
39 |
$0.00 |
| 94727 |
|
31 |
30 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
32 |
30 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
65 |
54 |
$0.00 |
| 84520 |
|
12 |
12 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 82553 |
|
297 |
283 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
776 |
369 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,047 |
921 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
671 |
608 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
174 |
121 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
980 |
867 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
99 |
49 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
78 |
74 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
101 |
70 |
$0.00 |
| 80320 |
|
32 |
26 |
$0.00 |
| 86901 |
|
31 |
26 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
34 |
28 |
$0.00 |
| 36416 |
|
21 |
21 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
30 |
13 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
18 |
13 |
$0.00 |